The Role of Inorganic Chemistry in the Development of Radiometal Agents for Cancer Therapy
- 24 November 1999
- journal article
- Published by American Chemical Society (ACS) in Accounts of Chemical Research
- Vol. 32 (12), 1053-1060
- https://doi.org/10.1021/ar980002c
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Targeted radiotherapy using Auger electron emittersPhysics in Medicine & Biology, 1996
- An Rh-105 complex of tetrathiacyclohexadecane diol with potential for formulating bifunctional chelatesNuclear Medicine and Biology, 1996
- Metabolism of receptor targeted 111In-DTPA-glycoproteins: Identification of 111In-DTPA-ϵ-lysine as the primary metabolic and excretory productNuclear Medicine and Biology, 1994
- Targeting Radiation to TumoursInternational Journal of Radiation Biology, 1994
- A phase II study of treatment of painful multifocal skeletal metastases with single and repeated dose samarium-153 ethylenediaminetetramethylene phosphonateEuropean Journal of Cancer and Clinical Oncology, 1991
- A perspective of monoclonal antibodies: Past, present, and futureSeminars in Nuclear Medicine, 1989
- Chemistry and Pharmacology of SMS 201-995, a Long-Acting Octapeptide Analogue of SomatostatinScandinavian Journal of Gastroenterology, 1986
- Calcium affinity of coordinated diphosphonate ligands. Single-crystal structure of [(en)2Co(O2P(OH)CH2P(OH)O2)]ClO4.H2O. Implications for the chemistry of technetium-99m-diphosphonate skeletal imaging agentsInorganic Chemistry, 1983
- Survey of Radiopharmaceuticals and Their Current StatusJournal of Pharmaceutical Sciences, 1974
- RADIOLABELED ANTIBODIESAnnals of the New York Academy of Sciences, 1957